Delivery Order SPE2DB20D9153-SPE2DB24FF21D
Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $5.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.0.5 ML, with a completion date of March 6, 2024 and a potential value of $4,321.56. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,762.08, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The award has a firm fixed-price pricing type and a completion date of May 2, 2024. This order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a potential value of $1,440.52 and a completion date of February 6, 2024. This award is part of a larger indefinite delivery contract, 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025, which enables DLA to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,202.60 order is for VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA, contract SPE2DB valued up to $4,999,999 through 2025, enabling DLA to place delivery orders for a wide range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, valued at $16,645.64, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.S ML vaccine. The contract has a completion date of March 4, 2024 and was awarded on March 1, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with the Defense...
- This is a $4,321.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The contract is to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of March 4, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the Defense Logistics Agency valued up to $4,999,999 through 2025, which enables the agency to issue delivery orders...
- This is a $5,762.08 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a performance period ending on February 13, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with the DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,440.52 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $4,371.22, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc., valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue delivery orders for a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $6,882.30 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA, contract 4600082013 under the SPE2DB program, valued up to...
- SPE2DB20D9153Indefinite Delivery Contract
- SPE2DB20D9153-SPE2DB24FF21DDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The order is for VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a potential value of $5,762.08 and a completion date of February 5, 2024. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025, which enables the Defense Logistics Agency to issue orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities globally. The contract does not have a set-aside designation.
Generated 5/3/24, 9:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 2/2/24 |